Evidence mapPaperPMID 27257347Full record

ArticleJournal of clinical biochemistry and nutrition2016

Okara ameliorates glucose tolerance in GK rats.

Masaya Hosokawa, Michiko Katsukawa, Hiroshi Tanaka, Hitomi Fukuda, Sonomi Okuno, Kinsuke Tsuda, Nobuko Iritani

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Masaya HosokawaFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Michiko KatsukawaFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Hiroshi TanakaFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Hitomi FukudaFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Sonomi OkunoFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Kinsuke TsudaFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Nobuko IritaniFaculty of Human Sciences, Tezukayama-gakuin University, 4-2-2 Harumidai, Minami-ku, Sakai, Osaka 590-0113, Japan.
Tezukayama Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Okara, a food by-product from the production of tofu and soy milk, is rich in three beneficial components: insoluble dietary fiber, β-conglycinin, and isoflavones. Although isoflavones and β-conglycinin have recently been shown to improve glucose tolerance, the effects of okara have not yet been elucidated. Therefore, we herein investigated the effects of okara on glucose tolerance in Goto-Kakizaki (GK) rats, a representative animal model of Japanese type 2 diabetes. Male GK rats were fed a 10% lard diet with or without 5% dry okara powder for 2 weeks and an oral glucose tolerance test was performed. Rats were then fed each diet for another week and sacrificed. The expression of genes that are the master regulators of glucose metabolism in adipose tissue was subsequently examined. No significant differences were observed in body weight gain or food intake between the two groups of GK rats. In the oral glucose tolerance test, increases in plasma glucose levels were suppressed by the okara diet. The mRNA expression levels of PPARγ, adiponectin, and GLUT4, which up-regulate the effects of insulin, were increased in epididymal adipose tissue by the okara diet. These results suggest that okara provides a useful means for treating type 2 diabetes.

Indexed as

adiponectinanimal modeldiabetes mellitusokaraPPARγ

Identifiers

PMID27257347
PMCPMC4865602
OpenAlexW2297042895

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.